News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO>MEDTIDE (03880.HK) Begins IPO Tdy w/ Entry Fee $3,091, Introduces CSPC PHARMA as Cornerstone Investor
CRDMO MEDTIDE (03880.HK) announced details of its Hong Kong IPO, planning to globally offer 16.8 million H shares, with 10% (approx. 1.68 million shares) for Hong Kong public offer...
Reset
Send
The window will close in 5 seconds
<IPO>MEDTIDE (03880.HK) Begins IPO Tdy w/ Entry Fee $3,091, Introduces CSPC PHARMA as Cornerstone Investor
Close
Recommend
23
Positive
35
Negative
17
 
SHORT SELL
 
STOCK INFO

CRDMO MEDTIDE (03880.HK) announced details of its Hong Kong IPO, planning to globally offer 16.8 million H shares, with 10% (approx. 1.68 million shares) for Hong Kong public offering and 90% (15.12 million shares) for international placement.

The offer price ranges from $28.4 to $30.6 per share, aiming to raise a maximum amount of approx. $514 million. The entry fee for a board lot of 100 shares is around $3,090.85.

Related NewsBOCI Lists Actively-Traded Stocks for CN-HK Southbound Link YTD (Table)
The offering period starts today (20th), and will end next Wednesday (25th), with listing expected on 30 June. Morgan Stanley and CITIC Securities are its joint sponsors.

In this IPO, MEDTIDE introduced CSPC PHARMA (01093.HK)  -0.060 (-0.787%)    Short selling $246.37M; Ratio 14.362%   and Welight Capital, founded by former TENCENT (00700.HK)  -6.100 (-1.207%)    Short selling $2.17B; Ratio 20.960%   executive Wu Xiaoguang, as cornerstone investors, subscribing shares equivalent to US$5 million each.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-20 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.